Remix Therapeutics

Remix Therapeutics Is Developing Novel Small Molecule Therapies. Remix Adopts a Completely New Strategy to Treat Diseases by Reprogramming the RNA Processing. As an Intermediate Step Between Transcription and Translation, RNA Can Be Regulated in Multiple Ways. Remix Is Designing Drugs Targeting the RNA Processing to Regulate the Process of mRNA Sequence Production. The Orally Available Small Molecule Drugs Designed by the Company Can Selectively Degrade RNA, Enhance Protein Expression by Increasing RNA Levels, Induce Exon Skipping, and More, Showing Potential for Treating Various Diseases Including Cancer, Central Nervous System Disorders, and Rare Diseases.